The Burden of Severely Drug-Refractory Epilepsy: A Comparative Longitudinal Evaluation of Mortality, Morbidity, Resource Use, and Cost Using German Health Insurance Data

Frontiers in Neurology
Adam StrzelczykJens-Peter Reese

Abstract

To evaluate long-term outcome of three years and treatment patterns of patients suffering from severely drug-refractory epilepsy (SDRE). This analysis was population-based and retrospective, with data collected from four million individuals insured by statutory German health insurance. ICD-10 codes for epilepsy (G40*) and intake of anticonvulsants were used to identify prevalent cases, which were then compared with a matched cohort drawn from the population at large. Insurance data were available from 2008 to 2013. Any patient who had been prescribed with at least four different antiepileptic drugs (AEDs) in an 18-month period was defined as an SDRE case. A total of 769 patients with SDRE were identified. Of these, 19% were children and adolescents; the overall mean age was 42.3 years, 45.4% were female and 54.6% male. An average of 2.7 AEDs per patient was prescribed during the first follow-up year. The AEDs most commonly prescribed were: levetiracetam (53.5%), lamotrigine (41.4%), valproate (41.3%), lacosamide (20.4%), and topiramate (17.8%). During 3-year follow-up, there was an annual rate of hospitalization in the range 42.7 to 55%, which was significantly higher than the 11.6-12.8% (p < 0.001) for the matched controls. Ad...Continue Reading

References

Feb 5, 2000·The New England Journal of Medicine·P Kwan, M J Brodie
Jun 26, 2001·Epilepsia·S KnakeUNKNOWN Status Epilepticus Study Group Hessen (SESGH)
Aug 28, 2001·Brain : a Journal of Neurology·F Rosenow, H Lüders
Mar 21, 2002·Epilepsy Research·A TettoUNKNOWN Osservatorio Regionale per l'Epilessia (OREp)
Aug 30, 2002·Epilepsia·Ettore BeghiUNKNOWN RESt-1 Group
Mar 1, 2003·Epilepsy & Behavior : E&B·Ann Jacoby
May 10, 2005·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·I ForsgrenM Ekman
Aug 16, 2005·PharmacoEconomics·Annika E SpottkeRichard Dodel
Jan 6, 2006·Epilepsia·José F Téllez-ZentenoSamuel Wiebe
Apr 21, 2006·American Journal of Epidemiology·M Alan BrookhartTil Stürmer
Jan 27, 2007·Annals of Neurology·Anna L Luciano, Simon D Shorvon
Mar 21, 2007·Epilepsy & Behavior : E&B·Vivian M J SmeetsFrans J N Nijhuis
Jan 2, 2008·Neurology·Yitzhak Schiller, Yussef Najjar
May 21, 2008·PharmacoEconomics·Adam StrzelczykHajo M Hamer
Aug 15, 2009·Epilepsy Research·Cecilie Johannessen LandmarkSvein I Johannessen
Aug 18, 2009·Epilepsia·Nathalie JettéSamuel Wiebe
Dec 31, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·P de FlonP Mattsson
Jul 14, 2010·PharmacoEconomics·Jasmina I IvanovaSue Caleo
Dec 24, 2010·The New England Journal of Medicine·Matti Sillanpää, Shlomo Shinnar
Jul 9, 2011·Lancet·Simon Shorvon, Torbjorn Tomson
Mar 3, 2012·Epilepsy & Behavior : E&B·Adam StrzelczykHajo M Hamer
Jun 14, 2012·Epilepsia·Athanasios GaitatzisJosemir W Sander
Jul 10, 2012·Epilepsy & Behavior : E&B·Vibhangini S WasadeLonni Schultz
Aug 24, 2012·Neurology·Christine St Germaine-SmithNathalie Jette
Oct 12, 2012·Journal of Neurology, Neurosurgery, and Psychiatry·Christian G BienChristian E Elger
Sep 3, 2013·Seizure : the Journal of the British Epilepsy Association·Adam StrzelczykHajo M Hamer
Jun 7, 2014·Epilepsia·David J ThurmanJacqueline A French
Sep 10, 2014·Acta Neurologica Scandinavica·K BolinA-M Landtblom
Jan 8, 2015·Seizure : the Journal of the British Epilepsy Association·Lena-Marie KortlandAdam Strzelczyk
Mar 25, 2015·Seizure : the Journal of the British Epilepsy Association·Anna H NodaAdam Strzelczyk

❮ Previous
Next ❯

Citations

Mar 1, 2019·Neuroreport·Zeinab GharaylouMahmoudreza Hadjighassem
Oct 9, 2018·Expert Review of Pharmacoeconomics & Outcomes Research·Aneta MelaMaciej Niewada
Aug 3, 2019·Brain : a Journal of Neurology·Stefan RamppMichael Buchfelder
Apr 3, 2020·Clinical Anatomy : Official Journal of the American Association of Clinical Anatomists & the British Association of Clinical Anatomists·Sanaz Ghaderi NiriTarik F Massoud
Aug 20, 2020·Expert Opinion on Pharmacotherapy·Adam StrzelczykSebastian Bauer
Dec 30, 2017·Expert Review of Clinical Pharmacology·Laurent M WillemsAdam Strzelczyk
Oct 13, 2018·European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society·René Danilo VerboketLaurent Maximilian Willems
Mar 20, 2018·Frontiers in Neurology·Rupert PageCraig Newman
Jun 27, 2019·Journal of Medical Economics·Jeremy D SlaterSharanya Murty
Feb 21, 2019·BMC Neurology·Virginia MumfordJeffrey Braithwaite
Jun 2, 2020·Current Medical Research and Opinion·Boulenouar MesraouaAli A Asadi-Pooya
Aug 7, 2020·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·René D VerboketLaurent M Willems
Aug 25, 2018·Frontiers in Neurology·Christoph BaumgartnerMichaela Rothmayer
Feb 13, 2021·Indian Journal of Pediatrics·Vykuntaraju K GowdaNaveen Benakappa
Mar 23, 2021·Der Nervenarzt·F RosenowUNKNOWN Österreichische Gesellschaft für Neurologie (ÖGN)
May 7, 2020·Epilepsy & Behavior : E&B·Rima NabboutNathalie Coque
Jul 16, 2021·Seizure : the Journal of the British Epilepsy Association·Adam StrzelczykSusanne Schubert-Bast

❮ Previous
Next ❯

Software Mentioned

STROSA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.